Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians

被引:32
作者
Chin, TM
Tan, SH
Lim, SE
Iau, P
Yong, WP
Wong, SW
Lee, SC
机构
[1] Natl Univ Singapore Hosp, Dept Haematol Oncol, Singapore 119074, Singapore
[2] Natl Univ Singapore Hosp, Dept Surg, Singapore 119074, Singapore
来源
CANCER DETECTION AND PREVENTION | 2005年 / 29卷 / 05期
关键词
cancer genetic counselling; breast cancers; barriers; motivators; cancer risk; cancer detection; self-administered questionaire; demographics; perceived breast cancer risk; genetic risk assessments; familiar cancer risks; predictive testing;
D O I
10.1016/j.cdp.2005.06.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Cancer genetic risk assessment clinics represent the primary prevention arm in oncology in identifying high-risk patients for screening and prevention, but deals with the taboo subject of cancer risk prediction. Low knowledge level and traditional beliefs may pose significant barriers to its acceptance in Asia. Methods: We conducted a questionnaire survey to evaluate the acceptance of breast cancer genetic counseling. Results: More than 70% of the 438 respondents indicated interest and perceived potential benefits. Higher education level and use of English were associated with greater acceptance. Learning about cancer risk and cancer detection, helping the family, and the doctor's recommendation, were important motivators, while misperception that cancer patients Could not gain personally, concerns of not understanding the information, cost issues. and fears of bad news, were important barriers. Conclusions: Singaporean women were receptive to cancer genetics counseling. Education to correct misperceptions may optimize utilization of a cancer genetics service. (c) 2005 International Society for Preventive Oncology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:412 / 418
页数:7
相关论文
共 21 条
[1]  
*ASCO, ASCO CURR CANC GEN C, V2
[2]   Motivations and concerns of women considering genetic testing for breast cancer: A comparison between affected and at-risk probands [J].
Brandt, R ;
Hartmann, E ;
Ali, Z ;
Tucci, R ;
Gilman, P .
GENETIC TESTING, 2002, 6 (03) :203-205
[3]   American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility [J].
Bruinooge, SS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2397-2406
[4]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[5]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .1. Hereditary nonpolyposis colon cancer [J].
Burke, W ;
Petersen, G ;
Lynch, P ;
Botkin, J ;
Daly, M ;
Garber, J ;
Kahn, MJE ;
McTiernan, A ;
Offit, K ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (11) :915-919
[6]  
Durfy SJ, 1999, CANCER EPIDEM BIOMAR, V8, P369
[7]   Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians [J].
Eisenbruch, M ;
Yeo, SS ;
Meiser, B ;
Goldstein, D ;
Tucker, K ;
Barlow-Stewart, K .
SOCIAL SCIENCE & MEDICINE, 2004, 59 (02) :235-248
[8]   Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition [J].
Escher, M ;
Sappino, AP .
ANNALS OF ONCOLOGY, 2000, 11 (09) :1131-1135
[9]  
Geller G, 1999, CANCER EPIDEM BIOMAR, V8, P377
[10]  
Glanz K, 1999, CANCER EPIDEM BIOMAR, V8, P329